SUSTAINED RESPONSE TO CRIZOTINIB MONOTHERAPY IN AN INFANT WITH GOPC-ROS1 FUSED CONGENITAL HEMISPHERIC GLIOMA

被引：0
|
作者：
Lulla, Rishi [1 ]
Svokos, Konstantina [2 ]
Pelton, Kristine [3 ]
Anthony, Douglas [4 ]
Touat, Mehdi [3 ]
Ligon, Keith L. [3 ]
机构：
[1] Brown Univ, Dept Pediat, Warren Alpert Sch Med, Providence, RI 02912 USA
[2] Brown Univ, Dept Neurosurg, Warren Alpert Sch Med, Providence, RI 02912 USA
[3] Dana Farber Canc Inst, Dept Oncol Pathol, Boston, MA 02115 USA
[4] Brown Univ, Dept Pathol, Warren Alpert Sch Med, Providence, RI 02912 USA
来源：
NEURO-ONCOLOGY | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
HGG-52
引用
收藏
页码：353 / 353
页数：1
相关论文
共 7 条
  • [1] INFANTILE HEMISPHERIC BRAIN TUMOR WITH A GOPC-ROS1 FUSION GENE: A CASE REPORT
    Taniguchi, Rieko
    Natsume, Atsushi
    Kawashima, Nozomu
    Tanioka, Shinji
    Muramatsu, Hideki
    Hamada, Motoharu
    Ichikawa, Daisuke
    Imaya, Masayuki
    Narita, Kotaro
    Kurimoto, Michihiro
    Shiba, Yoshiki
    Aoki, Kosuke
    Ohka, Fumiharu
    Hirato, Junko
    Wakabayashi, Toshihiko
    Takahashi, Yoshiyuki
    NEURO-ONCOLOGY, 2020, 22 : 377 - 377
  • [2] Oncogenic GOPC-ROS1 Fusion Identified in a Congenital Glioblastoma Case
    Whiteway, Susan L.
    Betts, Aaron M.
    O'Neil, Erika R.
    Green, Adam L.
    Gilani, Ahmed
    Orr, Brent A.
    Mathis, Derek A.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (08) : E813 - E818
  • [3] Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi
    Robertson, Susan J.
    Orme, Lisa
    Teixeira, Rodrigo
    Shamassi, Maryam
    Newell, Felicity
    Patch, Ann-Marie
    Yeh, Iwei
    Gard, Grace
    Wilmott, James
    Jackett, Louise
    LeBoit, Philip
    Fellowes, Andrew
    MacArthur, Grant
    Fox, Stephen
    Hayward, Nicholas K.
    Bastian, Boris
    Scolyer, Richard
    Waddell, Nicola
    Penington, Anthony
    Shackleton, Mark
    JAMA DERMATOLOGY, 2021, 157 (07) : 836 - 841
  • [4] GOPC-ROS1 Rearrangement as an Acquired Resistance Mechanism to Osimertinib and Responding to Crizotinib Combined Treatments in Lung Adenocarcinoma
    Zeng, Liang
    Yang, Nong
    Zhang, Yongchang
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (07) : E114 - E116
  • [5] Exceptional Response to Crizotinib With Subsequent Response to Cabozantinib in Metastatic, ROS1-GOPC Fusion-Mutated Breast Cancer
    O'Neil, Sean R.
    Weber, Garrett A.
    Deming, Dustin A.
    Burkard, Mark E.
    Kenny, Paraic A.
    Richmond, Craig S.
    Parsons, Benjamin M.
    JCO PRECISION ONCOLOGY, 2023, 7
  • [6] Two clinically distinct cases of infant hemispheric glioma carrying ZCCHC8:ROS1 fusion and responding to entrectinib
    Papusha, Ludmila
    Zaytseva, Margarita
    Panferova, Agnesa
    Druy, Alexander
    Valiakhmetova, Andge
    Artemov, Anton
    Salnikova, Ekaterina
    Kislyakov, Alexey
    Imyanitov, Evgeny
    Karachunsky, Alexander
    Maschan, Alexey
    Hwang, Eugene, I
    Novichkova, Galina
    Packer, Roger J.
    NEURO-ONCOLOGY, 2022, 24 (06) : 1029 - 1031
  • [7] Case Report: Short-Term Response to First-Line Crizotinib Monotherapy in a Metastatic Lung Adenocarcinoma Patient Harboring a Novel TPR-ROS1 Fusion
    Wei, Shuli
    Hu, Mangsha
    Yang, Yan
    Huang, Xiaojie
    Li, Baizhou
    Ding, Liren
    Wang, Pingli
    FRONTIERS IN ONCOLOGY, 2022, 12
1